Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Operating Expenses | 10,561 | 658 | 496 | 167 | 85 |
| Operating Income | -10,561 | -658 | -496 | -167 | -85 |
| Other Income | -399 | 94 | -246 | -547 | 0 |
| Pre-tax Income | -10,960 | -564 | -742 | -714 | -85 |
| Net Income Continuous | -10,960 | -564 | -742 | -714 | -85 |
| Net Income | $-10,960 | $-564 | $-742 | $-714 | $-85 |
| EPS Basic Total Ops | -15.00 | -1.00 | -1.00 | -1.00 | 0.00 |
| EPS Basic Continuous Ops | -14.80 | -0.78 | -1.20 | -0.99 | -0.12 |
| EPS Diluted Total Ops | -15.00 | -1.00 | -1.00 | -1.00 | 0.00 |
| EPS Diluted Continuous Ops | -14.80 | -0.78 | -1.20 | -0.99 | -0.12 |
| EBITDA(a) | $-10,543 | $-640 | $-440 | $-165 | $-85 |